--Worst 10 day stretch since the 10 days ending May 23, 2025, when it fell 9.17% --Down 46.25% from its all-time closing high of $113.45 on July 29, 2015 --Up 5.19% from 52 weeks ago (July 23, 2024), ...

Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...

Current parameters surrounding CVS Health represent a biased reward/risk ratio. Click here to see why I upgraded my rating of ...

CVS Health (CVS) closed the most recent trading day at $61.96, moving -2.12% from the previous trading session. This change lagged the S&P 500's 0.01% loss on the day. Elsewhere, the Dow lost 0.32%, ...

Rising prescription drug costs remain a top healthcare concern, with pharmacy benefit managers (PBMs) facing heightened scrutiny for their role in managing prescription drug benefits for insurers and ...

The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...

There's little point in pouring hundreds of millions of dollars into creating a biosimilar if PBMs will refuse to cover it.

Nuvem, a tech-enabled pharmacy service for community health providers, announced the addition of four seasoned executives to ...

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors ...